Get started
Author

Niklas J. Mackler

Will First-Responders Show Up for Work During a Pandemic? Lessons From a Smallpox Vaccination Survey of Paramedics
2007 · Niklas Mackler, William Wilkerson, et al. · Disaster management & response · 75
Drug Insight: use of docetaxel in prostate and urothelial cancers
2005 · Niklas J Mackler, Kenneth J Pienta · Nature Clinical Practice Urology · 64
Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder
2008 · David C. Smith, Niklas J. Mackler, et al. · The Journal of Urology · 62
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma
2020 · Sikander Ailawadhi, Rachael Sexton, et al. · Clinical Cancer Research · 17
PL03.06 EA5181: Phase 3 Trial of Concurrent and Consolidative Durvalumab vs Consolidation Durva Alone for Unresectable Stage 3 NSCLC
2025 · J.M. Varlotto, Y. Xie, et al. · Journal of Thoracic Oncology · 11
Phase II Evaluation of Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel in Patients with Hormone-Sensitive Prostate Adenocarcinoma
2007 · Niklas J. Mackler, Kenneth J. Pienta, et al. · Clinical Genitourinary Cancer · 10
Neoadjuvant paclitaxel (P), carboplatin (Ca) and gemcitabine (G) in patients with locally advanced transitional cell carcinoma (TCC) of the bladder: A final report
2006 · D. C. Smith, N. J. Mackler, et al. · Journal of Clinical Oncology · 4
Dose escalation of oral vinorelbine in combination with estramustine in hormone‐refractory adenocarcinoma of the prostate
2006 · Niklas J. Mackler, Rodney L. Dunn, et al. · Cancer · 2
PDF
The PI3K/AKT pathway in renal (clear cell) carcinoma via meta-analysis of expression microarrays
2005 · N. J. Mackler, M. Bhandari, et al. · Journal of Clinical Oncology · 2
Low vs high dose carfilzomib (Cfz) with dexamethasone (Dex) for relapsed/refractory multiple myeloma (RRMM): Results of SWOG S1304.
2018 · Sikander Ailawadhi, Rachael Sexton, et al. · Journal of Clinical Oncology · 1
Integrating Gene Expression With Recurrent Mutations Improves Age‐Stratified Risk Prediction in Acute Myeloid Leukemia
2026 · Mobina Shrestha, Salina Dahal, et al. · eJHaem
Abstract CT267: Temsirolimus (T) in patients (pts) with solid tumors with AKT1/3 amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
2024 · Deepti Behl, Michael Rothe, et al. · Cancer Research
Renal Toxicity with Carfilzomib in Multiple Myeloma: Secondary Analysis of SWOG S1304 Comparing Low-Dose Versus High-Dose Carfilzomib
2022 · Rajshekhar Chakraborty, Rachael Sexton, et al. · Blood
B-F1RST: Assessment of novel blood-based biomarkers in patients with first-line advanced or metastatic NSCLC receiving atezolizumab monotherapy.
2017 · Edward S. Kim, Mark A. Socinski, et al. · Journal of Clinical Oncology
Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate Presented in part at the 39th annual meeting of the American Society of Clinical Oncology, Chicago, Illinois, May 30–June 3, 2003.
2006 · Niklas J. Mackler, Rodney L. Dunn, et al.
Works count: 15
Citation count: 248
H-index: 6
I10-index: 6
Year
Topic
Type